Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-10-24 5:00 pm Purchase |
2023-10-20 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 1,093,188 16.400% |
179,000![]() (+19.58%) |
Filing History |
2023-10-13 5:00 pm Purchase |
2023-10-11 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 914,188 13.700% |
50,000![]() (+5.79%) |
Filing History |
2023-09-26 5:19 pm Purchase |
2023-09-22 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 864,188 13.000% |
48,060![]() (+5.89%) |
Filing History |
2023-09-22 5:21 pm Purchase |
2023-09-20 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 816,128 12.200% |
153,600![]() (+23.18%) |
Filing History |
2023-09-15 5:29 pm Unchanged |
2023-09-13 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 662,528 9.900% |
0 (Unchanged) |
Filing History |
2023-08-08 4:41 pm Unchanged |
2023-08-04 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 662,528 9.900% |
0 (Unchanged) |
Filing History |
2023-07-17 4:34 pm Unchanged |
2023-07-17 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 662,528 9.900% |
0 (Unchanged) |
Filing History |
2023-06-23 10:40 am Purchase |
2023-06-22 | 13D | Nano Dimension Ltd. NNDM |
Anson Funds Management LP | 15,599,863 6.200% |
15,599,863![]() (New Position) |
Filing History |
2023-05-30 4:57 pm Purchase |
2023-05-19 | 13D | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 662,528 9.900% |
131,630![]() (+24.79%) |
Filing History |
2023-05-02 10:39 am Purchase |
2023-04-25 | 13D | Nano Dimension Ltd. NNDM |
Anson Funds Management LP | 15,599,863 6.200% |
2,347,727![]() (+17.72%) |
Filing History |
2023-03-10 11:29 am Purchase |
2023-03-09 | 13D | Nano Dimension Ltd. NNDM |
Anson Funds Management LP | 13,252,136 5.100% |
13,252,136![]() (New Position) |
Filing History |
2023-02-14 4:15 pm Sale |
2022-12-31 | 13G | Mudrick Capital Acquisition Corporation II MUDS |
Anson Funds Management LP | 0 0.000% |
-2,050,000![]() (Position Closed) |
Filing History |
2023-02-14 4:08 pm Unchanged |
2022-12-31 | 13G | LogicMark, Inc. LGMK |
Anson Funds Management LP | 1,975 9.900% |
0 (Unchanged) |
Filing History |
2023-02-14 4:08 pm Purchase |
2022-12-31 | 13G | View, Inc. VIEW |
Anson Funds Management LP | 409,953 9.900% |
409,953![]() (New Position) |
Filing History |
2023-02-14 4:07 pm Unchanged |
2022-12-31 | 13G | Appreciate Holdings, Inc. SFRT |
Anson Funds Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | MEI Pharma, Inc. MEIP |
Anson Funds Management LP | 530,898 8.000% |
506,550![]() (+2080.42%) |
Filing History |
2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | Model Performance Acquisition Corp. MPAC |
Anson Funds Management LP | 0 0.000% |
-456,461![]() (Position Closed) |
Filing History |
2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | GO Acquisition Corp. GOAC |
Anson Funds Management LP | 0 0.000% |
-3,268,543![]() (Position Closed) |
Filing History |
2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Equity Distribution Acquisition Corp. EQD |
Anson Funds Management LP | 0 0.000% |
-2,969,179![]() (Position Closed) |
Filing History |
2022-04-18 4:21 pm Unchanged |
2022-04-18 | 13D | Amarantus BioScience Holdings, Inc. AMBS |
Anson Funds Management LP | 14,176,424 4.990% |
0 (Unchanged) |
Filing History |